January 31, 2024 – Until recently, most patients with lymphoma who did not respond well to chemotherapy had a grim diagnosis, measured in months. However, new research into CAR-T therapy is offering new hope to these patients, with excellent long-term results. Chimeric antigen receptor T-cell (CAR-T) therapy was developed more